BATS BZX Real-Time Price
As of 9:39am ET
| +0.21 / +4.86%|
The 3 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 12.00 and a low estimate of 1.00. The median estimate represents a +10.38% increase from the last price of 4.53.
The current consensus among 3 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.